Evolving Genomic Approaches to Idiopathic Pulmonary Fibrosis: Moving Beyond Genes

Abstract excerpt

A little more than 10 years ago, the completed sequencing of the human genome boldly promised to usher in an era of enhanced understanding and accelerated development of treatments for most human diseases. Ten years later, many of these therapeutic goals have not been reached, but genomic technologies have dramatically enhanced our understanding of how genes and gene networks contribute to the pathogenesis of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
• Share to Lung Cancer Treatments and Mutations
• Share to Pulmonary Hypertension Research and Treatments